Question special

Given that systemic immunosuppressants and anti-inflammatory medications are commonly prescribed in dermatology, what has been the effect of the COVID pandemic on these prescriptions? Are patients more hesitant to take these medications? Are providers more cautious to prescribe? Are there special concerns for patients with underlying pre-existing conditions or advanced age?